Chordate Medical launches the trademark Ozilia
Chordate Medical introduces its new trademark, Ozilia, for the company’s preventive migraine treatment, formerly known as K.O.S. The new brand name will debut in the international arena during the International Headache Congress in Seoul, the largest global gathering of headache and migraine specialists. BioStock had the opportunity to discuss the company’s new trademark with CEO Anders Weilandt.
Medtech company Chordate Medical has developed a new treatment method for chronic migraine that is nerve-stimulating and drug-free. This treatment method has previously been called Kinetic Oscillation Stimulation (K.O.S), but now the company is launching the treatment under the brand name Ozilia.
For Chordate Medical, the new brand represents a strategic step in the roll-out and commercialisation of the migraine treatment in the company’s focus markets. Ozilia will replace K.O.S as a trademark in all markets where Chordate Medical operates.
Migraines mainly affect women
Migraine is a widespread disease that affects about 1.5 million Swedes, of which about 65 per cent are women. Since migraine is often classified as a women’s disease, Chordate Medical has chosen a name that naturally connects to this reality. In addition, the Spanish female name Ozilia has a meaning that reflects the company’s vision:
»The meaning of the name Ozilia revolves around her need for freedom – and that is also the core of what we want to offer to all people in the world who suffer from migraines.« – Anders Weilandt, CEO Chordate Medical
CEO Anders Weilandt talks about Ozilia
The company will present the new trademark at the International Headache Congress (IHC), which takes place in Seoul on September 14-17. In addition, Dr. Hoffmann will present the company’s latest study results, which show that Ozilia provides a significant reduction in the number of headache days for patients with chronic migraines.
BioStock contacted Chordate Medical’s CEO Anders Weilandt to learn more about the company’s work and the introduction of Ozilia.
According to your press release, K.O.S. has been too technical and uninspiring as a brand name. How did you come up with the name Ozilia?
– We wanted to find a name that you as a patient can easily remember, something that gives you confidence – a friend – someone to help you. The way to get there was through play with the word oscillation, which is the unique core of our technology.
What values and messages do you hope to convey with the new trademark?
– When we found Ozilia as an alternative and looked at the linguistic and cultural background to the name, we found a quote that accurately captures what we want to convey, which is freedom from migraines:
»Ozilia is a free spirit who always seeks change, adventure and excitement. The core around which her life revolves is freedom, just as a bird needs its wings to survive, she needs freedom for its survival.«
You are planning the launch of the new brand name at IHC in Seoul – what are your expectations on the conference?
– It will be incredibly exciting to present Ozilia and our unique technology for preventive migraine treatment without drugs.
– The global leaders in migraine care, research and industry are gathered at this congress, which is our first international exhibition.
– Our expectation is to be able to create many good contacts to support the commercialisation project.
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.»It will be incredibly exciting to present Ozilia and our unique technology for preventive migraine treatment without drugs. The global leaders in migraine care, research and industry are gathered at this congress, which is our first international exhibition.«
